The Ministry of Economic Development has drafted amendments to the Code of Administrative Offenses (KoAP): companies that launch a generic drug before the original patent expires could face a fine ranging from 50% to 200% of the revenue generated from its sales. Under the proposal, Rospatent (the Federal Service for Intellectual Property) would be authorized to draw up administrative protocols, and the accounts of the infringing parties could be frozen. If a generic drug has not yet been brought to market, a fine of 50,000 to 200,000 rubles is stipulated. The amendments could come into effect on September 1, 2027.
Separately, the Federal Antimonopoly Service (FAS) already has the authority to classify the market launch of a generic drug as "unfair competition" and, in certain cases, demands that the revenue earned from such sales be remitted to the state budget.
Kommersant published an article featuring commentary from Darya Ermolina, Managing Partner at Ermolina & Partners, who notes:
"The fine under this provision could be higher—up to 200% of revenue—whereas the FAS currently mandates the remittance of 100% of revenue to the state budget. In other words, this fine would more effectively serve the purposes of administrative punishment and the prevention of future violations."
The full text of the article is available at the link (in Russian).
Separately, the Federal Antimonopoly Service (FAS) already has the authority to classify the market launch of a generic drug as "unfair competition" and, in certain cases, demands that the revenue earned from such sales be remitted to the state budget.
Kommersant published an article featuring commentary from Darya Ermolina, Managing Partner at Ermolina & Partners, who notes:
"The fine under this provision could be higher—up to 200% of revenue—whereas the FAS currently mandates the remittance of 100% of revenue to the state budget. In other words, this fine would more effectively serve the purposes of administrative punishment and the prevention of future violations."
The full text of the article is available at the link (in Russian).